Cargando…
Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
Gastrointestinal (GI) cancers that include all cancers of the digestive tract organs are generally associated with obesity, lack of exercising, smoking, poor diet, and heavy alcohol consumption. Treatment of GI cancers typically involves surgery followed by chemotherapy and/or radiation. Unfortunate...
Autores principales: | Pidkovka, Nataliya, Belkhiri, Abbes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353021/ https://www.ncbi.nlm.nih.gov/pubmed/37469409 http://dx.doi.org/10.3389/fonc.2023.1079041 |
Ejemplares similares
-
AXL Promotes Metformin-Induced Apoptosis Through Mediation of Autophagy by Activating ROS-AMPK-ULK1 Signaling in Human Esophageal Adenocarcinoma
por: Hong, Jun, et al.
Publicado: (2022) -
Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers
por: Pidkovka, Nataliya, et al.
Publicado: (2021) -
AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto, Ross A, et al.
Publicado: (2015) -
AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis
por: Goyette, Marie-Anne, et al.
Publicado: (2022) -
Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
por: Breitenecker, Kristina, et al.
Publicado: (2023)